id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0436-0030,FDA,FDA-2011-D-0436,International Conference on Harmonisation; Guidance; Q11 Development and Manufacture of Drug Substances,Other,Guidance,2019-10-21T04:00:00Z,2019,10,2019-10-21T04:00:00Z,,2024-11-12T05:09:04Z,,1,0,090000648116ed85
FDA-2011-D-0436-0029,FDA,FDA-2011-D-0436,01 Final Guidance for Industry Q11 Development and Manufacture of Drug Substances--Questions and Answers (Chemical Entities and BiotechnologicalBiological Entities),Other,Guidance,2018-02-26T05:00:00Z,2018,2,2018-02-26T05:00:00Z,,2024-11-07T01:22:26Z,,1,0,0900006482f632d2
FDA-2011-D-0436-0028,FDA,FDA-2011-D-0436,"Q11 Development and Manufacture of Drug Substances—Questions and
Answers (Chemical Entities and Biotechnological/Biological Entities);
International Council for Harmonisation; Guidance for Industry;  Availability",Notice,Notice of Availability,2018-02-26T05:00:00Z,2018,2,2018-02-26T05:00:00Z,,2018-02-26T16:48:04Z,2018-03809,0,0,0900006482f61eec
FDA-2011-D-0436-0026,FDA,FDA-2011-D-0436,International Conference on Harmonisation; Guidance Availability: Q11 Development and Manufacture of Drug Substances,Notice,Notice of Availability,2012-11-20T05:00:00Z,2012,11,2012-11-20T05:00:00Z,,2012-11-20T15:21:44Z,2012-28142,0,0,090000648116e95a
FDA-2011-D-0436-0001,FDA,FDA-2011-D-0436,Draft Guidance on Q11 Development and Manufacture of Drug Substances; Availability: International Conference on Harmonisation,Notice,Notice of Availability,2011-06-29T04:00:00Z,2011,6,2011-06-29T04:00:00Z,2011-09-02T03:59:59Z,2011-06-29T16:56:50Z,2011-16255,0,0,0900006480eb650e
FDA-2011-D-0436-0002,FDA,FDA-2011-D-0436,Q11 Development and Manufacture of Drug Substances; International Conference on Harmonisation - Draft Guidance,Other,Guidance,2011-06-29T04:00:00Z,2011,6,2011-06-29T04:00:00Z,,2019-08-21T18:36:13Z,,0,0,0900006480eb66f1